NCI Explores AI to Screen For and Treat Pancreatic Cancer
The institute sees the emerging technology supporting treatment for patients by better controlling tumor growth.
A new initiative at the National Cancer Institute aims to create capabilities for detecting pancreatic cancer early and improving treatments for patients with mutations.
A big challenge with pancreatic cancer resides in the KRAS gene. When mutated, the gene can cause normal cells to become cancerous. A new therapy involving KRAS inhibitors and genetic testing can help patients screen for this earlier.
Dr. Christine Alewine, the NIH Lasker Scholar in the Laboratory of Molecular Biology at NCI’s Center for Cancer Research, discussed this breakthrough, how new advancements can serve as an alternative treatment for chemotherapy and where AI can make an impact. Plus, she notes how other health issues such as diabetes also plays a role in screening for pancreatic cancer.
-
Dr. Christine Alewine NIH Lasker Scholar in the Laboratory of Molecular Biology, Center for Cancer Research NCI
-
VA Aims to Build a More Connected Digital Experience for Veterans
Officials outlined progress on EHR modernization, VA.gov updates and digital identity verification to improve veterans’ access to benefits.
4m read -
Health Agency Moves: CMS Names Acting CIO, CDC AI Lead Departs
CMS and CDC are navigating technology leadership transitions as federal health agencies expand their AI and modernization efforts.
2m read -
War Department Rebrands CDAO to Super Intelligence Office
The Pentagon's Chief Digital and Artificial Intelligence Office is now the Super Intelligence Office amid new terminology for the tech.
2m read -
Federal Agencies Turn to AI to Improve Call Center Efficiency
Leaders from GAO, Army and CDW discuss how AI is modernizing federal call centers, improving efficiency and enhancing customer service.
37m watch Partner Content
